Phenylpropanolamine is a drug used to relieve nasal congestion due to colds, hay fever, upper respiratory allergies, and sinusitis. It is available in nonprescription products alone and in combination with other nonprescription drugs, to treat symptoms of allergy, colds, and upper respiratory infections. Phenylpropanolamine is also used as an adjunct to calorie restriction in short-term weight loss. It is available in nonprescription products alone and in combination with other ingredients for weight loss.
The Food and Drug Administration (FDA) has taken steps to remove phenylpropanolamine from all drug products and has issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is an ingredient used in many over-the-counter (OTC) and prescription cough and cold medications as a decongestant and in over-the-counter weight loss products. Phenylpropanolamine has been found to increase the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any products that contain phenylpropanolamine.
Replenish Depleted Nutrients | none |
Reduce Side Effects | none |
Support Medicine | none |
Reduces Effectiveness | none |
Potential Negative Interaction |
Explanation Required | none |
Copyright © 2024 TraceGains, Inc. All rights reserved.
RxAnswers™ is a copyrighted product from TraceGains.
This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.
There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.
Learn more about TraceGains, the company.
Learn more about the authors of RxAnswers.
TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.
Information expires December 2024.